Chong-Kin Liam Selected Research

Chong-Kin Liam Research Topics

12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 11/2005
5	Asthma (Bronchial Asthma) 01/2021 - 01/2013
5	Adenocarcinoma of Lung 07/2018 - 05/2006
4	Neoplasms (Cancer) 09/2022 - 09/2013
3	Lung Neoplasms (Lung Cancer) 06/2023 - 01/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 04/2023 - 10/2016
2	Neoplasm Metastasis (Metastasis) 08/2020 - 11/2011
2	Tuberculosis (Tuberculoses) 12/2013 - 10/2002
2	Disease Progression 09/2012 - 05/2006
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Adenocarcinoma 12/2018
1	Lung Diseases (Lung Disease) 10/2016
1	Infections 04/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2013
1	Pneumothorax 12/2013
1	Carcinoma (Carcinomatosis) 11/2011
1	Respiratory Insufficiency (Respiratory Failure) 11/2011
1	Pleural Effusion (Pleural Effusions) 11/2011
1	Lymphangitis 11/2011

16	ErbB Receptors (EGF Receptor)IBA 06/2023 - 05/2006
6	Tyrosine Kinase InhibitorsIBA 01/2021 - 05/2006
4	osimertinibIBA 09/2019 - 12/2017
3	AfatinibIBA 01/2021 - 07/2018
2	Gefitinib (Iressa)FDA Link 09/2012 - 05/2006
1	Bronchodilator Agents (Bronchodilators)IBA 04/2023
1	anlotinibIBA 09/2022
1	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2021
1	Deoxyglucose (2 Deoxy D glucose)IBA 08/2020
1	Interleukin-17 (Interleukin 17)IBA 10/2017
1	InterleukinsIBA 10/2017
1	Monoclonal AntibodiesIBA 10/2017
1	AlkanesIBA 10/2016
1	Formoterol Fumarate Drug Combination Budesonide FDA Link 06/2014
1	AntralIBA 04/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2013
1	Anaplastic Lymphoma KinaseIBA 09/2013
1	CytokinesIBA 01/2013
1	Interleukin-13IBA 01/2013
1	Gemcitabine FDA Link 11/2005
1	Carboplatin (JM8)FDA LinkGeneric 11/2005
1	Tuberculin (PPD)IBA 10/2002

5	Therapeutics 12/2018 - 05/2006
3	Nebulizers and Vaporizers (Inhaler) 01/2021 - 01/2015
2	Drug Therapy (Chemotherapy) 09/2022 - 11/2005
1	Immunotherapy 09/2022
1	Diathermy 12/2013
1	Nephrectomy 12/2013
1	Bronchoscopes 12/2013